Real Life Sciences logoRLS logo small
RLS Protect logo white

Resource Library

  • Categories
  • Data Anonymization with Short Timelines & Missing Datasets

    Performing Quantitative Risk Assessments Without Access To Trial Datasets The sponsor organization started the PRCI process with an initial Process...

    Anonymizing Rare Disease Data

    Avoiding Delays when seeking compliance for Rare Disease Populations The challenges facing the Sponsor required the  Real Life Sciences and...

    Proactively Preparing For Risk Based Disclosure Submissions Across Therapeutic Areas

    Operationalizing a scalable process to manage growing demands for anonymization Most sponsors are experiencing pressure to achieve deadlines from Regulators...

    Rare Disease Data & Document Anonymization

    "ULTRAGENYX is committed to sharing information about our research to help advance future development in rare diseases. Performing robust, accurate...
    crossmenu